Wearable sensors reveal hidden diabetes risk in PCOS women
NCT ID NCT07483723
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
Polycystic ovary syndrome (PCOS) affects many women and raises the risk of type 2 diabetes. This study will use a continuous glucose monitor worn for 14 days to track blood sugar patterns in 80 women with different PCOS subtypes. The goal is to see which subtypes have the worst glucose control, helping doctors tailor prevention efforts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify which PCOS subtypes are at highest risk for diabetes, leading to more personalized monitoring and prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health outcomes, and results may not change current clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU Amiens
RECRUITINGSalouël, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a traditional herbal remedy tame type 2 diabetes?
- Can a Weight-Loss drug tame PCOS hormones?
- Can decades of lifting weights keep the Brain's muscle signals young?
- Could a pancreatic peptide hold clues to PCOS-Related insulin resistance?
- A blood marker may reveal how well diabetes treatments are working
- A sweet drink before heart surgery? trial tests if carbs can ease stress in children